Dr Daniel Wiseman is an Honorary Consultant Haematologist at The Christie, NHS Foundation Trust, Manchester, and has great expertise in treating patients with CMML (Chronic Myelomonocytic Leukemia). This is a recording of a Zoom presentation he gave to the MDS UK Patient Support Group called  'Perspectives on CMML: Diagnosis & Treatment.'  Following the presentation, there are Q&As between Dr. Wiseman and a group of patients.  The session was chaired by Chris Dugmore, Trustee, Volunteer Coordinator and Local Patient Support Ambassador (Essex region).

Dr Daniel Wiseman is an Honorary Consultant Haematologist at The Christie and a Clinician Scientist with a research group based at the CRUK (Cancer Research UK) Manchester Institute/Manchester Cancer Research Centre. He was awarded a Clinician Scientist grant from Bloodwise to research myeloid malignancies, and the Oglesby Leukaemia Clinical Research Fellowship to establish a research programme for Chronic Myelomonocytic Leukaemia (CMML), in Manchester. At the same time he was appointed an Honorary Consultant in Haematology at The Christie, where he leads the Myelodysplasia (MDS) service and is Principle Investigator on several MDS and related clinical trials.